NYXHNyxoah SA Ordinary Shares

NAS · US · Healthcare · Medical Instruments & Supplies · nyxoah.com

1.600USDMkt Cap: 160.12M $P/E: —3d ago

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for …

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$135.72BUSDP/E 43.4

EssilorLuxottica Societe anonyme

$81.53BUSDP/E 30.5

BDX

Becton, Dickinson and Company

$52.30BUSDP/E 33.2

MDLN

Medline Inc. Class A Common Stock

West Pharmaceutical Services, Inc.

$24.85BUSDP/E 45.2

DIM

Sartorius Stedim Biotech

$20.46BUSDP/E 64.5

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$14.73BUSDP/E 69.1

SOLV

Solventum Corporation Common Stock

$15.25BUSDP/E 10.9

COO

The Cooper Companies, Inc.

$14.87BUSDP/E 64.6

BAX

Baxter International Inc.

$13.62BUSD

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap160.12M $

Enterprise Value126.32M $

Revenue (TTM)21.66M $

Gross Profit6.33M $

Net Income (TTM)-90.08M $

Revenue/Share0.4870 USD

Last Price1.600 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees153

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-1.69

PEG—

EV/EBITDA-1.53

EV/Revenue5.83

P/S7.58

P/B1.71

EPS (TTM)-2.54

EPS (Forward)-0.97

52W Range

1.58523% of range1.650

52W High1.650 USD

52W Low1.585 USD

Profitability

Gross Margin63.13%

Oper. Margin-268.25%

EBITDA Margin0.00%

Profit Margin-899.05%

ROE-183.36%

ROA-76.04%

Growth

Revenue Growth472.80%

Earnings Growth—

Cash Flow & Leverage

Operating CF-68.98M $

CapEx (TTM)3.77M $

FCF Margin-212.62%

FCF Yield-28.77%

Net Debt-37.80M $

Net Debt/EBITDA0.46

Balance Sheet

Debt/Equity0.82

Current Ratio2.38

Quick Ratio2.28

Book Value/Sh0.9608 USD

Cash/Share0.9770 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating2.0 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)4.384 USD

Upside (mean)+174.0%

Target Range3.042 USD – 6.054 USD

$3.042+174.0% to mean$6.054

# Analysts3

Ownership

Shares Out.100.07M

Float50.88M

Insiders33.78%

Institutions30.43%

Short Interest

Short Ratio2.3d

Short % Float0.50%

Short % Out.0.44%

Shares Short438.56K

Short (prev mo.)298.47K

Technical

SMA 501.554 (+3.0%)

SMA 2003.397 (-52.9%)

Beta0.95

S&P 52W Chg21.00%

Avg Vol (30d)164.06K

Avg Vol (10d)109.97K

Technical Indicators

RSI (14)52.0

MACD0.0034

MACD Signal-0.0256

MACD Hist.+0.0290

BB Upper1.717 USD

BB Middle1.508 USD

BB Lower1.300 USD

BB Width27.65%

ATR (14)0.0819 USD

Vol Ratio (20d)1.41x